| Long-term survival | |||
---|---|---|---|---|
Variable | OR | 95% CI | p | |
Age at metastasis ≤ 65 years (yes versus no) | 1.95 | 0.96–3.97 | 0.064 | |
Single site metastases versus multiple sites | 1.76 | 0.87–3.58 | 0.114 | |
First-line therapy | Chemotherapy plus bevacizumab versus other | 2.49 | 1.13–5.52 | 0.024 |
Surgical resection of metastasis (yes versus no) | 3.96 | 1.96–8.02 | < 0.001 | |
Local non-surgical treatment of metastasis (yes versus no) | 3.32 | 1.64–6.71 | 0.001 |